Biologics Market Share, Size, and Outlook by 2031
Biologics Market: Strategic Insights
Biologics Market
-
CAGR (2023 - 2031)18.2% -
Market Size 2023
US$ 469.2 Billion -
Market Size 2031
US$ 1,793.9 Billion
Market Dynamics
GROWTH DRIVERS
- Increasing Prevalence of Chronic Diseases
FUTURE TRENDS
- Strategic Initiatives by Companies
OPPORTUNITIES
- Evolution of Biotechnology in Developing Regions
Key Players
- AbbVie Inc
- Pfizer Inc
- Samsung Biologics
- ADMA Biologics Inc
- WuXi Biologics
- Catalent Inc
- AGC Biologics
- AstraZeneca
- Amgen Inc
- Avecia Biologics
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Product - Monoclonal Antibodies
- Vaccines
- Recombinant Hormones/Proteins
- Cell and Gene Therapies
Application - Cancer
- Infectious Diseases
- Autoimmune Diseases
Source - Mammalian
- Microbial
Manufacturing - Outsourced
- In-House
Get Free Sample For